Engineering the future of heart attack care.
Engineering the future of heart attack care.
We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.
Engineering the future of heart attack care
Engineering the future of heart attack care
Engineering the future of heart attack care
Engineering the future of heart attack care
We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.
When there's no solution
When there's no solution
1 out of 2 heart attack patients still develops microvascular obstruction (MVO), blockage in the heart’s smallest blood vessels — even after timely treatment. MVO remains a major driver of poor recovery, heart failure, and long-term mortality after heart attack treatment.
A first-in-class ultrasound catheter solution for PCI
We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.
A first-in-class ultrasound catheter solution for PCI
We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.
Strategic medtech partnerships and investor inquiries
Strategic medtech partnerships and investor inquiries
SonoRobotics develops catheter-based ultrasound technology for thrombus disruption and microvascular protection in PCI workflows.
0+
Years of Research
0+
Years of Research
0+
Patents & Pending patent
0+
Patents & Pending patent